Krystal Biotech reported a gross margin of 94.60% and a net margin of 45.94% for the quarter ended Jun 2026. These financial ratios cover 37 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2016 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||
| Gross Margin | 97.39% | 93.19% | 94.66% | 91.45% | 92.03% | 94.57% | 94.30% | 92.54% | 95.64% | 93.85% | 94.57% | 94.60% | |||||||||||||||||||||||||
| EBT Margin | 943.75% | 25.29% | 2.06% | 22.82% | 35.51% | 53.35% | 49.43% | 48.70% | 49.05% | 47.74% | 52.79% | 55.43% | |||||||||||||||||||||||||
| EBIT Margin | -303.80% | 7.71% | -14.75% | 12.18% | 26.80% | 45.41% | 41.10% | 41.02% | 42.30% | 41.33% | 46.12% | 49.00% | |||||||||||||||||||||||||
| EBITDA Margin | -303.80% | 7.71% | -14.75% | 12.18% | 26.80% | 45.41% | 41.10% | 41.02% | 42.30% | 41.33% | 46.12% | 49.00% | |||||||||||||||||||||||||
| Operating Margin | -303.80% | 7.71% | -14.75% | 12.18% | 26.80% | 45.41% | 41.10% | 41.02% | 42.30% | 41.33% | 46.12% | 49.00% | |||||||||||||||||||||||||
| Net Margin | 943.75% | 20.62% | 2.06% | 22.15% | 32.41% | 49.95% | 40.47% | 39.91% | 81.15% | 47.98% | 48.05% | 45.94% | |||||||||||||||||||||||||
| FCF Margin | -249.31% | -18.81% | 16.41% | -6.09% | 70.53% | 57.77% | 28.08% | 52.92% | 38.81% | 70.37% | 62.92% | 59.74% | |||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.01B | 0.01B | 0.01B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B | ||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 0.45B | 0.54B | 0.62B | 0.61B | 0.59B | 0.57B | 0.55B | 0.61B | 0.74B | 0.80B | 0.84B | 0.89B | 0.95B | 1.02B | 1.07B | 1.11B | 1.19B | 1.29B | 1.37B | 1.45B | |||||||||||||||||
| Invested CapitalInvested Cap. | |||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.01 | 0.06 | 0.11 | 0.19 | 0.25 | 0.29 | 0.31 | 0.32 | 0.31 | 0.30 | 0.31 | 0.30 | |||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | |||||||||||||||||||||||||||||||||||||
| Debt Ratio | |||||||||||||||||||||||||||||||||||||
| Times Interest Earned | |||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -74.21 | -80.06 | -33.28 | -57.91 | -57.10 | -72.28 | -42.80 | -98.89 | 40.50 | 403.02 | 0.00B | 338.65 | 192.67 | 99.11 | 145.96 | 103.73 | 64.47 | 140.04 | 135.95 | 200.85 | |||||||||||||||||
| Price to SalesP/S | 382.26 | 83.12 | 112.05 | 74.99 | 62.44 | 49.51 | 59.08 | 41.40 | 52.32 | 67.20 | 65.33 | 92.26 | |||||||||||||||||||||||||
| Price to BookP/B | 2.84 | 2.97 | 3.11 | 3.01 | 3.31 | 3.91 | 4.22 | 5.03 | 4.33 | 4.50 | 6.35 | 6.28 | 5.91 | 4.77 | 5.29 | 3.82 | 4.50 | 5.90 | 5.96 | 8.09 | |||||||||||||||||
| Enterprise Value | 0.82B | 1.33B | 1.27B | 1.26B | 1.40B | 1.66B | 1.71B | 2.81B | 2.71B | 2.97B | 4.54B | 4.71B | 4.65B | 3.91B | 4.59B | 3.29B | 4.39B | 6.37B | 6.78B | 10.15B | |||||||||||||||||
| EV to EBIT | -52.26 | -60.58 | -25.31 | -43.81 | -44.44 | -47.79 | -35.12 | -73.77 | -104.20 | 914.69 | -678.89 | 550.14 | 206.76 | 94.58 | 126.71 | 83.61 | 106.00 | 143.87 | 126.30 | 173.82 | |||||||||||||||||
| EV to EBITDA | -52.26 | -60.58 | -25.31 | -43.81 | -44.44 | -47.79 | -35.12 | -73.77 | -104.20 | 914.69 | -678.89 | 550.14 | 206.76 | 94.58 | 126.71 | 83.61 | 106.00 | 143.87 | 126.30 | 173.82 | |||||||||||||||||
| Market Capitalization | 1.16B | 1.76B | 1.71B | 1.69B | 1.79B | 2.04B | 2.07B | 3.28B | 3.27B | 3.50B | 5.08B | 5.27B | 5.23B | 4.51B | 5.21B | 3.98B | 5.12B | 7.20B | 7.60B | 11.00B | |||||||||||||||||
| Price to FCFP/FCF | -47.26 | -28.54 | -52.19 | -28.29 | -53.10 | -74.09 | -54.32 | -98.56 | -153.33 | -441.86 | 682.99 | -0.00B | 88.52 | 85.70 | 210.40 | 78.24 | 134.81 | 95.49 | 103.83 | 154.44 | |||||||||||||||||
| EV to FCF | -33.30 | -21.45 | -38.89 | -21.14 | -41.42 | -60.33 | -45.10 | -84.23 | -126.98 | -374.74 | 610.57 | -0.00B | 78.57 | 74.34 | 185.49 | 64.82 | 115.54 | 84.51 | 92.59 | 142.57 | |||||||||||||||||
| EV to CFO | -112.74 | -63.41 | -82.05 | -29.25 | -70.98 | -74.42 | -65.56 | -82.09 | -127.60 | -410.80 | 285.61 | -0.00B | 78.94 | 74.06 | 148.33 | 62.48 | 110.58 | 82.17 | 84.36 | 135.77 | |||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -303.80% | 7.71% | -14.75% | 12.18% | 26.80% | 45.41% | 41.10% | 41.02% | 42.30% | 41.33% | 46.12% | 49.00% | |||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -13.81% | -13.31% | -18.56% | -20.27% | -23.59% | -26.96% | -28.19% | -26.21% | -20.81% | -14.21% | -8.56% | -2.56% | 3.21% | 7.17% | 11.02% | 13.68% | 14.43% | 13.62% | 14.21% | 14.97% | |||||||||||||||||
| Return on Assets [ROA]ROA | -13.04% | -12.98% | -16.95% | -19.38% | -22.72% | -24.67% | -25.13% | -23.21% | -3.93% | 0.99% | 6.84% | 11.96% | 5.51% | 8.75% | 11.64% | 13.26% | 16.73% | 15.91% | 16.48% | 16.67% |